S, A., WY, J., M, Y., I, D., J, S., S, L., . . . N, D. (2025). Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3-tyrosine kinase domain mutations: Prognostic implications of NPM1 co-mutation. Cancer, 131(16), e70032. https://doi.org/10.1002/cncr.70032
Chicago Style (17th ed.) CitationS, Arora, et al. "Outcomes of Patients with Newly Diagnosed Acute Myeloid Leukemia with FLT3-tyrosine Kinase Domain Mutations: Prognostic Implications of NPM1 Co-mutation." Cancer 131, no. 16 (2025): e70032. https://doi.org/10.1002/cncr.70032.
MLA (9th ed.) CitationS, Arora, et al. "Outcomes of Patients with Newly Diagnosed Acute Myeloid Leukemia with FLT3-tyrosine Kinase Domain Mutations: Prognostic Implications of NPM1 Co-mutation." Cancer, vol. 131, no. 16, 2025, p. e70032, https://doi.org/10.1002/cncr.70032.